Wir haben unsere Website aktualisiert! Schauen Sie sich um, teilen Sie uns Ihre Meinung mit oder besuchen Sie die archivierte Website.
Save the Date: Join us April 28 - May 2 for the 2027 MDF International Conference in Seattle, Washington!
IMPORTANT: Find all anesthesia guides for individuals and their families and healthcare professionals
Abonnieren Sie den monatlichen Newsletter MyDispatch – Bleiben Sie über Fortschritte in der Forschung auf dem Laufenden

Nicholas Johnson, MD, MSCI, FAAN

11958 West Broad Street, Henrico, VA 23233

Clinic: Short Pump Pavilion

Specialty

Neurology

Community Submission Recommendations

DM1, DM2

Other locations

Ambulatory Care Center

Children's Pavilion

Featured in the Digital Academy

How Common is Myotonic Dystrophy in the United States? Findings from the Recent ...

Published: April 24, 2020

This presentation will discuss the outcome of the recent study exploring the prevalence of myotonic dystrophy type 1 in the United Stat...

What Comes Next: Preparing for DM Clinical Trials - 2020 Virtual Conference

Published: Oktober 5, 2020

With many potential drugs and treatments in development, this session explores the different stages of the clinical trials process

ARTHEx biotech - Meet the DM Drug Developers

Published: Juni 19, 2021

Each month biotechnology, pharmaceutical and academic partners, large and small, working on treatments

Clinical Trial Readiness Workshop

Published: September 28, 2021

Originally presented on September 11th, 2021 as a part of the DM1 & DM2 Tracks at the 2021 Virtual MDF Annual Conference.

Clinical Updates: Cardiac Management, DM Clinical Research Network, and Brain Ma...

Published: September 28, 2021

Originally presented on September 11th, 2021 as a part of the Professionals Track at the 2021 Virtual MDF Annual Conference.

Research Dataset Presentations - 2022 MDF Annual Conference

Published: November 4, 2022

Suzanne McDermott, PhD, presents, Groups of Signs and Symptoms in adult-onset myotonic dystrophy type 1.

Avidity Biosciences Dec 2022 - Meet the DM Drug Developers

Published: Dezember 16, 2022

Each month biotechnology, pharmaceutical and academic partners, large and small

Avidity Biosciences Topline Data - 2023 Meet the DM Drug Developers

Published: Mai 24, 2023

Sarah Boyce, Avidity CEO, Dr. Steve Hughes, Avidity CMO

DM-Medikamentenentwicklung und Zulassungsaspekte mit der FDA – Jährliche MDF-Kon...

Published: November 21, 2023

Gewinnen Sie Einblicke und Verständnis für die wichtige Rolle, die die FDA im Medikamentenzulassungsprozess spielt, durch eine Präsenta...

Pharma Day mit Euro-DyMA – MDF-Konferenz 2025

Published: Juni 16, 2025

Die 5. Ausgabe des Pharma Day wurde in Partnerschaft von Euro-DyMA (European Dystrophia Myotonica Association) und der Myotonic Dystrop...